Recent medical evidence indicates that using medical marijuana can help slow the development of Alzheimer’s disease. The primary component, tetrahydrocannabinol (THC), reduces and prevents the development of neural protein deposits deep within the brain. This degenerative neural disease is largely caused by these deposits. Medical marijuana dispensaries monitor the development of these protein deposits or sticky amyloid plaques, which cause neuronal damage, impair memory and cognition, cause extreme memory loss, and cause confusion, irritability, mood changes, spatial disorientation, and speech difficulties. Check out here House of Dank Medical Cannabis – Bel-Air – Cannabis Dispensary
Alzheimer’s disease is a progressive and terminal disease that damages brain cells, resulting in memory loss, dementia, and impaired motor functions, as well as reduced intelligence and social skills. Alzheimer’s disease is one of the top ten causes of death for Americans over the age of 65. Medical cannabis appears to be a successful drug treatment for Alzheimer’s disease and some of its symptoms, according to research.
Although Medical Marijuana (MMJ) is legal in some parts of the United States, all MMJ card holders are required to purchase Medical Cannabis from a licenced dispensary. A medical marijuana dispensary will also assist a patient in obtaining their medical marijuana card.
Alzheimer’s disease is a degenerative disease characterised by a progressive loss of memory and intellectual capacity. It is an incurable and fatal disease that mostly affects people over the age of 65. MMJ lowers the level of the essential neurotransmitter acetylcholine and reduces the production of the neural enzyme acetylcholinesterase, which causes the formation of harmful protein deposits in the brain.
Although alcohol, opium, cocaine, and nicotine suppress and inhibit the development of new brain cells, recent clinical studies conducted by Scripps Research Institute in San Diego show that marijuana promotes neuron growth. This house, along with its regulated and supervised distribution through various medical marijuana dispensaries, strongly supports its medicinal use.
There are also a variety of pharmaceutical medications that have been shown to inhibit the formation of new brain cells. In clinical trials involving almost half of lung cancer patients, medical cannabis from dispensaries reduces tumour growth and inflammation, despite the fact that it does the exact opposite. Patients with Alzheimer’s disease experience significant relief from their symptoms thanks to a licenced pharmacy that provides them with the right dosage of Medical Marijuana to manage their symptoms.